RE: only used to small numbers. The recent CEO Update of 31 July mentions 500,000 PENsannual sales production within 2 years, therefore:
- 500,000 x $50 purchase net to EKG for each PEN = $25M annual
- Assuming 500,000 x $60 annual recurring revenuemonitoring fee net to EKG ($5 x 12 months) = $30M note this is recurring revenue increasing exponentially yearly
- Total = $55M annual revenue (not including exponential recurring revenue stream)
- X price to revenue ratio of say 4 x $55M = $220M valuation lets use 100 M shares FD
- $2 + sp in 2 years